These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 11520127)

  • 1. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
    Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
    Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
    Liu XX; Wilson K; Charlton CG
    Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous analysis of catechol-O-methyl transferase activity, S-adenosylhomocysteine and adenosine.
    Reenilä I; Rauhala P
    Biomed Chromatogr; 2010 Mar; 24(3):294-300. PubMed ID: 19629963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.
    Benson R; Crowell B; Hill B; Doonquah K; Charlton C
    Neurochem Res; 1993 Mar; 18(3):325-30. PubMed ID: 8479601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat.
    Huang ZZ; Mato JM; Kanel G; Lu SC
    Hepatology; 1999 May; 29(5):1471-8. PubMed ID: 10216131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a novel isoform of methionine adenosyl transferase 2A and increased S-adenosylmethionine turnover in lung epithelial cells exposed to hyperoxia.
    Panayiotidis MI; Stabler SP; Ahmad A; Pappa A; Legros LH; Hernandez-Saavedra D; Schneider BK; Allen RH; Vasiliou V; McCord JM; Kotb M; White CW
    Free Radic Biol Med; 2006 Jan; 40(2):348-58. PubMed ID: 16413417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
    Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
    Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.
    De Bonis ML; Tessitore A; Pellecchia MT; Longo K; Salvatore A; Russo A; Ingrosso D; Zappia V; Barone P; Galletti P; Tedeschi G
    Neurosci Lett; 2010 Jan; 468(3):287-91. PubMed ID: 19909787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values.
    Reenilä I; Männistö PT
    Med Hypotheses; 2001 Nov; 57(5):628-32. PubMed ID: 11735324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.
    Müller T
    Int Rev Neurobiol; 2010; 95():49-71. PubMed ID: 21095459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-Methylation of tea polyphenols catalyzed by human placental cytosolic catechol-O-methyltransferase.
    Zhu BT; Patel UK; Cai MX; Conney AH
    Drug Metab Dispos; 2000 Sep; 28(9):1024-30. PubMed ID: 10950844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
    Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
    Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase and Parkinson's disease.
    Reches A; Fahn S
    Adv Neurol; 1984; 40():171-9. PubMed ID: 6695593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa.
    Charlton CG; Crowell B
    Life Sci; 2000 Apr; 66(22):2159-71. PubMed ID: 10834300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased catechol-O-methyltransferase activity and protein expression in OX-42-positive cells in the substantia nigra after lipopolysaccharide microinfusion.
    Helkamaa T; Reenilä I; Tuominen RK; Soinila S; Väänänen A; Tilgmann C; Rauhala P
    Neurochem Int; 2007; 51(6-7):412-23. PubMed ID: 17573159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
    Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of catechol O-methyltransferase.
    Vidgren J; Svensson LA; Liljas A
    Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of catecholamine metabolizing enzymes cause changes in S-adenosylmethionine and S-adenosylhomocysteine in the rat brain.
    Yassin MS; Cheng H; Ekblom J; Oreland L
    Neurochem Int; 1998 Jan; 32(1):53-9. PubMed ID: 9460702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.